Login / Signup

Intranasal oxytocin suppresses seizure-like behaviors in a mouse model of NGLY1 deficiency.

Yukimasa MakitaMakoto AsahinaReiko FujinawaHiroshi YukitakeTadashi Suzuki
Published in: Communications biology (2024)
NGLY1 deficiency is a genetic disease caused by biallelic mutations of the Ngly1 gene. Although epileptic seizure is one of the most severe symptoms in patients with NGLY1 deficiency, preclinical studies have not been conducted due to the lack of animal models for epileptic seizures in NGLY1 deficiency. Here, we observed the behaviors of male and female Ngly1 -/- mice by video monitoring and found that these mice exhibit spontaneous seizure-like behaviors. Gene expression analyses and enzyme immunoassay revealed significant decreases in oxytocin, a well-known neuropeptide, in the hypothalamus of Ngly1 -/- mice. Seizure-like behaviors in Ngly1 -/- mice were transiently suppressed by a single intranasal administration of oxytocin. These findings suggest the therapeutic potential of oxytocin for epileptic seizure in patients with NGLY1 deficiency and contribute to the clarification of the disease mechanism.
Keyphrases
  • gene expression
  • high fat diet induced
  • temporal lobe epilepsy
  • mouse model
  • dna methylation
  • genome wide
  • skeletal muscle
  • single cell
  • metabolic syndrome
  • cell therapy
  • sleep quality
  • drug induced
  • case control